Loading
Loading
Organ & Bioregulator Research · 20mg
Janoshik-tested · 10 vials per kit
Ovagen is a synthetic tetrapeptide bioregulator studied in preclinical research for its hepatoprotective and gastrointestinal effects. Research has examined its potential to treat hepatitis, mitigate complications from chemotherapy, alleviate medication side effects, improve environmental toxin exposure effects, and support liver function in aging models. Studies have explored applications in liver disease prevention and gastrointestinal dysfunction.
≥98%
Purity
Lyophilised
Format
2–3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock — weekday same/next-day delivery available.
Chemical Properties
Need to work out your dose?
Use our reconstitution calculator — syringe units in seconds.
Research Use Only — Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
Ovagen
Ovagen is a synthetic tetrapeptide developed as an ovarian bioregulator in the Khavinson series. It is studied for regulatory effects on ovarian follicular cell populations and reproductive hormone production in the context of ovarian ageing and menopause-related decline.
Like other Khavinson peptides, Ovagen is proposed to act via chromatin binding in ovarian granulosa and theca cells, modulating gene expression related to steroidogenesis (oestrogen, progesterone), FSH receptor expression, and follicular cell survival.
Research in aged female animal models describes preservation of ovarian follicle counts and improvement in oestrogen secretion capacity. Combination with other endocrine bioregulators in longevity protocols is described in the Russian gerontological literature.
For research reference only. All information pertains to preclinical or published human trial data. Not intended as medical advice. This product is for research use only.
Don't have supplies? Grab them while you're here.
